To elucidate the regulatory activity of GLI1 on the antitumorigenic proteins CysLT2R and 15-PGDH and the differentiation marker Mucin-2 in colon cancer, we used a tissue microarray (TMA) of primary CRCs from 326 patients22. This evidence concerns the gene GLI1 and malignant colon neoplasm.